MENU
ADXN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Addex Therapeutics (ADXN) Ownership - Who owns Addex Therapeutics?
Profile
Industry
N/A
Address
Chemin des Aulx 12
Phone
+41 228841555
Employees
24
Web
https://www.addextherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.78M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
1.35M
Risk (Beta)
1.68
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
0.79 USD as % of share price
Fundamentals
ADXN
Capitalization
8.78M
P/E Ratio
N/A
Risk (Beta)
1.68
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.79%
Revenue
1.35M
ROE
N/A
Book Value
N/A
P/B Ratio
0.68
Cash Flow
N/A
Earnings
-15.6
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
0.71
Current Revenue Per Employee
10151.31
Dividends Per Share - Security
N/A
EBITDA
-10.59M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-211.39
Shares Held By Institutions
32.1K
Shares Outstanding - Current
1.07M
Total Liabilities
N/A
Total Volume MTD
N/A
Value
1
Gain YTD
28.926
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Chemin des Aulx 12
Phone
+41 228841555
Employees
24
Web
https://www.addextherapeutics.com